Share Price and Basic Stock Data
Last Updated: November 19, 2025, 11:42 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Catvision Ltd operates in the Trading & Distributors industry, with a current market capitalization of ₹16.0 Cr and a share price of ₹29.4. The company’s revenue has shown a downward trend, with sales standing at ₹21.55 Cr for the fiscal year ending March 2023, down from ₹21.67 Cr in March 2022. The trailing twelve months (TTM) revenue is slightly higher at ₹21.17 Cr. Quarterly sales fluctuated throughout 2023, peaking at ₹5.84 Cr in September 2022 before declining to ₹4.79 Cr by September 2023. This volatility indicates challenges in maintaining consistent sales performance. The sales figures reflect an industry environment that may be facing headwinds, impacting overall demand. The company’s operating profit margin (OPM) has been negative, recorded at -8.56% as of March 2025, highlighting operational inefficiencies. The overall trend suggests that Catvision is struggling to adapt to market conditions, necessitating strategic adjustments to stabilize and grow revenue streams.
Profitability and Efficiency Metrics
Catvision Ltd’s profitability metrics reveal significant challenges, with a net profit of ₹-0.40 Cr for the fiscal year ending March 2023, a decline from ₹0.13 Cr in March 2022. The operating profit for March 2024 was reported at ₹-0.18 Cr, indicating a further deterioration in profitability. The company’s return on equity (ROE) stood at 1.02%, and the return on capital employed (ROCE) was recorded at 1.27%, both of which are low compared to industry averages, suggesting inefficient capital utilization. The interest coverage ratio (ICR) of 13.51x reflects a strong capacity to cover interest expenses, although the overall financial performance raises concerns about sustainability. Additionally, the cash conversion cycle (CCC) of 203.77 days indicates inefficiencies in managing working capital, particularly in inventory and receivables management, further exacerbating the profitability challenges faced by the company.
Balance Sheet Strength and Financial Ratios
Catvision Ltd’s balance sheet shows no reported borrowings, which is a positive indicator of financial stability. The company maintains a price-to-book value (P/BV) ratio of 0.58x, suggesting that the stock may be undervalued compared to its book value. However, the lack of reserves indicates a vulnerability in financial buffers, which could hinder the company’s ability to absorb operational shocks. The current ratio of 1.90x indicates adequate short-term liquidity, but the quick ratio of 1.31x suggests reliance on inventory for liquidity, which may not be ideal. The company’s debt-to-equity ratio remains low, reinforcing its debt-free status. However, the declining trends in profitability and operational efficiency metrics could pose risks to future financial health. The net profit margin of -1.50% for March 2025 further underscores the pressing need for strategic financial management.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Catvision Ltd indicates a significant public ownership of 66.89%, with promoters holding 33.10% as of March 2025. This ownership structure may reflect a lack of institutional interest, as Foreign Institutional Investors (FIIs) have not reported any holdings, and Domestic Institutional Investors (DIIs) hold a minimal 0.01%. The gradual increase in promoter stake from 29.21% in December 2022 to 33.10% in March 2025 could signal confidence from the promoters in their long-term strategy, but the diminishing public shareholding could raise concerns among retail investors. The number of shareholders has fluctuated, standing at 4,347 in March 2025, down from 5,265 in March 2024, indicating potential investor discontent or reduced confidence in the company’s future prospects. This scenario could influence the stock’s liquidity and market perception.
Outlook, Risks, and Final Insight
The outlook for Catvision Ltd appears challenging due to persistent operational inefficiencies and declining profitability metrics. The company must address its high cash conversion cycle and negative operating margins to regain investor confidence and improve financial performance. Risks include market volatility, which could further impact sales, and the lack of reserves that limits financial flexibility. On the positive side, the absence of debt provides a cushion against financial distress, allowing for potential strategic investments without the burden of interest payments. Should the company successfully implement efficiency measures and stabilize its revenue streams, it could position itself for recovery. However, failure to address these systemic issues may lead to continued underperformance and potential operational risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Catvision Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 67.7 Cr. | 3.53 | 5.59/3.20 | 45.2 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Modella Woollens Ltd | 6.36 Cr. | 69.9 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 96.2 Cr. | 47.0 | 49.8/10.2 | 107 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 109 Cr. | 98.3 | 174/84.4 | 15.5 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Muller and Phipps (India) Ltd | 13.8 Cr. | 220 | 570/208 | 172 | 22.9 | 0.00 % | % | % | 10.0 |
| Industry Average | 12,254.14 Cr | 166.16 | 88.69 | 122.48 | 0.36% | 15.57% | 8.99% | 7.71 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.05 | 4.60 | 5.84 | 5.56 | 5.61 | 5.12 | 4.79 | 5.22 | 4.97 | 4.80 | 5.65 | 4.90 | 4.79 |
| Expenses | 5.37 | 4.60 | 5.58 | 5.28 | 5.56 | 5.04 | 4.73 | 5.41 | 5.09 | 4.61 | 5.55 | 4.81 | 5.20 |
| Operating Profit | -0.32 | -0.00 | 0.26 | 0.28 | 0.05 | 0.08 | 0.06 | -0.19 | -0.12 | 0.19 | 0.10 | 0.09 | -0.41 |
| OPM % | -6.34% | -0.00% | 4.45% | 5.04% | 0.89% | 1.56% | 1.25% | -3.64% | -2.41% | 3.96% | 1.77% | 1.84% | -8.56% |
| Other Income | 0.61 | 0.05 | 0.06 | -0.24 | 0.12 | 0.08 | 0.08 | 0.10 | 6.72 | 0.05 | 0.11 | 0.09 | 0.32 |
| Interest | 0.13 | 0.12 | 0.15 | 0.12 | 0.06 | 0.01 | 0.02 | -0.00 | -0.05 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.22 | 0.21 | 0.21 | 0.21 | 0.22 | 0.18 | 0.18 | 0.18 | 0.16 | 0.12 | 0.17 | 0.13 | 0.22 |
| Profit before tax | -0.06 | -0.28 | -0.04 | -0.29 | -0.11 | -0.03 | -0.06 | -0.27 | 6.49 | 0.11 | 0.03 | 0.04 | -0.32 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0.62% | -0.00% | -0.00% | -250.00% | 81.25% |
| Net Profit | -0.05 | -0.27 | -0.04 | -0.29 | -0.11 | -0.03 | -0.06 | -0.27 | 6.46 | 0.11 | 0.03 | 0.13 | -0.57 |
| EPS in Rs | -0.09 | -0.50 | -0.07 | -0.53 | -0.20 | -0.06 | -0.11 | -0.50 | 11.85 | 0.20 | 0.06 | 0.24 | -1.05 |
Last Updated: August 1, 2025, 5:35 am
Below is a detailed analysis of the quarterly data for Catvision Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 4.79 Cr.. The value appears to be declining and may need further review. It has decreased from 4.90 Cr. (Dec 2024) to 4.79 Cr., marking a decrease of 0.11 Cr..
- For Expenses, as of Mar 2025, the value is 5.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.81 Cr. (Dec 2024) to 5.20 Cr., marking an increase of 0.39 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.41 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Dec 2024) to -0.41 Cr., marking a decrease of 0.50 Cr..
- For OPM %, as of Mar 2025, the value is -8.56%. The value appears to be declining and may need further review. It has decreased from 1.84% (Dec 2024) to -8.56%, marking a decrease of 10.40%.
- For Other Income, as of Mar 2025, the value is 0.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Dec 2024) to 0.32 Cr., marking an increase of 0.23 Cr..
- For Interest, as of Mar 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.01 Cr..
- For Depreciation, as of Mar 2025, the value is 0.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Dec 2024) to 0.22 Cr., marking an increase of 0.09 Cr..
- For Profit before tax, as of Mar 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Dec 2024) to -0.32 Cr., marking a decrease of 0.36 Cr..
- For Tax %, as of Mar 2025, the value is 81.25%. The value appears to be increasing, which may not be favorable. It has increased from -250.00% (Dec 2024) to 81.25%, marking an increase of 331.25%.
- For Net Profit, as of Mar 2025, the value is -0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 0.13 Cr. (Dec 2024) to -0.57 Cr., marking a decrease of 0.70 Cr..
- For EPS in Rs, as of Mar 2025, the value is -1.05. The value appears to be declining and may need further review. It has decreased from 0.24 (Dec 2024) to -1.05, marking a decrease of 1.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.22 | 32.61 | 50.13 | 56.69 | 77.57 | 43.87 | 29.53 | 21.71 | 21.67 | 21.55 | 20.09 | 19.97 | 21.17 |
| Expenses | 31.31 | 30.81 | 45.50 | 53.51 | 71.96 | 42.64 | 28.94 | 20.30 | 20.85 | 21.03 | 20.27 | 19.93 | 21.39 |
| Operating Profit | 1.91 | 1.80 | 4.63 | 3.18 | 5.61 | 1.23 | 0.59 | 1.41 | 0.82 | 0.52 | -0.18 | 0.04 | -0.22 |
| OPM % | 5.75% | 5.52% | 9.24% | 5.61% | 7.23% | 2.80% | 2.00% | 6.49% | 3.78% | 2.41% | -0.90% | 0.20% | -1.04% |
| Other Income | 0.02 | 0.04 | -0.14 | 0.53 | 0.37 | 0.05 | 0.41 | 0.32 | 0.76 | 0.05 | 6.99 | 0.50 | 0.66 |
| Interest | 0.67 | 0.56 | 0.85 | 1.08 | 0.89 | 1.09 | 0.81 | 0.59 | 0.55 | 0.44 | -0.02 | 0.04 | 0.03 |
| Depreciation | 0.57 | 0.71 | 0.50 | 0.49 | 0.57 | 0.68 | 0.78 | 0.83 | 0.84 | 0.84 | 0.69 | 0.64 | 0.64 |
| Profit before tax | 0.69 | 0.57 | 3.14 | 2.14 | 4.52 | -0.49 | -0.59 | 0.31 | 0.19 | -0.71 | 6.14 | -0.14 | -0.23 |
| Tax % | 20.29% | 10.53% | 33.76% | 35.05% | 33.41% | 8.16% | -13.56% | -54.84% | 31.58% | 0.00% | 0.65% | 114.29% | |
| Net Profit | 0.56 | 0.52 | 2.08 | 1.40 | 3.00 | -0.54 | -0.52 | 0.48 | 0.13 | -0.71 | 6.10 | -0.30 | -0.40 |
| EPS in Rs | 1.03 | 0.95 | 3.81 | 2.57 | 5.50 | -0.99 | -0.95 | 0.88 | 0.24 | -1.30 | 11.19 | -0.55 | -0.73 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 38.93% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7.14% | 300.00% | -32.69% | 114.29% | -118.00% | 3.70% | 192.31% | -72.92% | -646.15% | 959.15% | -104.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | 307.14% | -332.69% | 146.98% | -232.29% | 121.70% | 188.60% | -265.22% | -573.24% | 1605.31% | -1064.07% |
Catvision Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -7% |
| 3 Years: | -2% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | % |
| TTM: | -1900% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 27% |
| 3 Years: | 24% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 0% |
| 3 Years: | -1% |
| Last Year: | -1% |
Last Updated: September 5, 2025, 2:51 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70.76 | 75.66 | 53.44 | 59.43 | 50.07 | 91.35 | 97.40 | 99.87 | 92.81 | 70.63 | 57.23 | 46.97 |
| Inventory Days | 124.44 | 128.75 | 127.46 | 121.73 | 70.17 | 154.51 | 196.14 | 307.64 | 276.81 | 291.41 | 313.47 | 333.51 |
| Days Payable | 57.35 | 49.62 | 36.29 | 70.26 | 54.15 | 76.07 | 54.76 | 65.51 | 73.99 | 62.92 | 39.24 | 176.72 |
| Cash Conversion Cycle | 137.84 | 154.79 | 144.61 | 110.90 | 66.09 | 169.80 | 238.78 | 341.99 | 295.62 | 299.12 | 331.45 | 203.77 |
| Working Capital Days | 65.05 | 62.23 | 45.29 | 24.66 | 22.68 | 65.89 | 80.84 | 140.55 | 161.53 | 176.66 | 124.63 | 80.42 |
| ROCE % | 8.52% | 6.93% | 19.92% | 12.34% | 20.54% | 2.54% | 0.98% | 3.67% | 3.13% | 0.98% | -1.97% | -1.27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.77 | 10.99 | -1.60 | 0.24 | 0.66 |
| Diluted EPS (Rs.) | -0.77 | 10.99 | -1.60 | 0.24 | 0.66 |
| Cash EPS (Rs.) | 0.62 | 12.46 | 0.23 | 1.78 | 2.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 42.16 | 42.94 | 31.94 | 33.47 | 33.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 42.16 | 42.94 | 31.94 | 33.47 | 33.23 |
| Revenue From Operations / Share (Rs.) | 36.94 | 36.84 | 39.52 | 39.73 | 39.81 |
| PBDIT / Share (Rs.) | 0.98 | 0.58 | 1.91 | 2.88 | 3.17 |
| PBIT / Share (Rs.) | -0.19 | -0.68 | 0.37 | 1.34 | 1.64 |
| PBT / Share (Rs.) | -0.26 | 11.25 | -1.29 | 0.33 | 0.56 |
| Net Profit / Share (Rs.) | -0.55 | 11.18 | -1.30 | 0.23 | 0.87 |
| NP After MI And SOA / Share (Rs.) | -0.58 | 11.00 | -1.60 | 0.23 | 0.66 |
| PBDIT Margin (%) | 2.66 | 1.59 | 4.84 | 7.25 | 7.95 |
| PBIT Margin (%) | -0.52 | -1.86 | 0.94 | 3.36 | 4.11 |
| PBT Margin (%) | -0.71 | 30.53 | -3.27 | 0.84 | 1.41 |
| Net Profit Margin (%) | -1.50 | 30.35 | -3.29 | 0.60 | 2.19 |
| NP After MI And SOA Margin (%) | -1.59 | 29.85 | -4.05 | 0.60 | 1.65 |
| Return on Networth / Equity (%) | -1.39 | 25.61 | -5.01 | 0.71 | 1.98 |
| Return on Capital Employeed (%) | -0.43 | -1.56 | 1.13 | 3.55 | 4.45 |
| Return On Assets (%) | -0.97 | 20.50 | -3.95 | 0.44 | 1.21 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.08 | 0.07 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.24 | 0.34 |
| Asset Turnover Ratio (%) | 0.65 | 0.78 | 0.83 | 0.73 | 0.70 |
| Current Ratio (X) | 1.90 | 3.41 | 3.63 | 2.12 | 1.92 |
| Quick Ratio (X) | 1.31 | 2.16 | 1.68 | 1.17 | 0.85 |
| Inventory Turnover Ratio (X) | 1.82 | 0.43 | 0.58 | 0.86 | 0.89 |
| Interest Coverage Ratio (X) | 13.51 | -17.03 | 2.35 | 2.88 | 2.94 |
| Interest Coverage Ratio (Post Tax) (X) | -6.64 | 21.81 | 0.44 | 1.24 | 1.81 |
| Enterprise Value (Cr.) | 9.82 | 5.17 | 7.09 | 10.41 | 8.85 |
| EV / Net Operating Revenue (X) | 0.48 | 0.25 | 0.32 | 0.48 | 0.40 |
| EV / EBITDA (X) | 18.27 | 16.14 | 6.80 | 6.62 | 5.12 |
| MarketCap / Net Operating Revenue (X) | 0.66 | 0.55 | 0.33 | 0.28 | 0.14 |
| Price / BV (X) | 0.58 | 0.47 | 0.41 | 0.33 | 0.16 |
| Price / Net Operating Revenue (X) | 0.66 | 0.55 | 0.33 | 0.28 | 0.14 |
| EarningsYield | -0.02 | 0.54 | -0.12 | 0.02 | 0.11 |
After reviewing the key financial ratios for Catvision Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.77. This value is below the healthy minimum of 5. It has decreased from 10.99 (Mar 24) to -0.77, marking a decrease of 11.76.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.77. This value is below the healthy minimum of 5. It has decreased from 10.99 (Mar 24) to -0.77, marking a decrease of 11.76.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 3. It has decreased from 12.46 (Mar 24) to 0.62, marking a decrease of 11.84.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.16. It has decreased from 42.94 (Mar 24) to 42.16, marking a decrease of 0.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.16. It has decreased from 42.94 (Mar 24) to 42.16, marking a decrease of 0.78.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.94. It has increased from 36.84 (Mar 24) to 36.94, marking an increase of 0.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 2. It has increased from 0.58 (Mar 24) to 0.98, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 0. It has increased from -0.68 (Mar 24) to -0.19, marking an increase of 0.49.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.26. This value is below the healthy minimum of 0. It has decreased from 11.25 (Mar 24) to -0.26, marking a decrease of 11.51.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 2. It has decreased from 11.18 (Mar 24) to -0.55, marking a decrease of 11.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.58. This value is below the healthy minimum of 2. It has decreased from 11.00 (Mar 24) to -0.58, marking a decrease of 11.58.
- For PBDIT Margin (%), as of Mar 25, the value is 2.66. This value is below the healthy minimum of 10. It has increased from 1.59 (Mar 24) to 2.66, marking an increase of 1.07.
- For PBIT Margin (%), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 10. It has increased from -1.86 (Mar 24) to -0.52, marking an increase of 1.34.
- For PBT Margin (%), as of Mar 25, the value is -0.71. This value is below the healthy minimum of 10. It has decreased from 30.53 (Mar 24) to -0.71, marking a decrease of 31.24.
- For Net Profit Margin (%), as of Mar 25, the value is -1.50. This value is below the healthy minimum of 5. It has decreased from 30.35 (Mar 24) to -1.50, marking a decrease of 31.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 8. It has decreased from 29.85 (Mar 24) to -1.59, marking a decrease of 31.44.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.39. This value is below the healthy minimum of 15. It has decreased from 25.61 (Mar 24) to -1.39, marking a decrease of 27.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -0.43. This value is below the healthy minimum of 10. It has increased from -1.56 (Mar 24) to -0.43, marking an increase of 1.13.
- For Return On Assets (%), as of Mar 25, the value is -0.97. This value is below the healthy minimum of 5. It has decreased from 20.50 (Mar 24) to -0.97, marking a decrease of 21.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.65. It has decreased from 0.78 (Mar 24) to 0.65, marking a decrease of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 3.41 (Mar 24) to 1.90, marking a decrease of 1.51.
- For Quick Ratio (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has decreased from 2.16 (Mar 24) to 1.31, marking a decrease of 0.85.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 4. It has increased from 0.43 (Mar 24) to 1.82, marking an increase of 1.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.51. This value is within the healthy range. It has increased from -17.03 (Mar 24) to 13.51, marking an increase of 30.54.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -6.64. This value is below the healthy minimum of 3. It has decreased from 21.81 (Mar 24) to -6.64, marking a decrease of 28.45.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9.82. It has increased from 5.17 (Mar 24) to 9.82, marking an increase of 4.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.48, marking an increase of 0.23.
- For EV / EBITDA (X), as of Mar 25, the value is 18.27. This value exceeds the healthy maximum of 15. It has increased from 16.14 (Mar 24) to 18.27, marking an increase of 2.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.66, marking an increase of 0.11.
- For Price / BV (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.58, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.66, marking an increase of 0.11.
- For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.54 (Mar 24) to -0.02, marking a decrease of 0.56.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Catvision Ltd:
- Net Profit Margin: -1.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -0.43% (Industry Average ROCE: 14.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.39% (Industry Average ROE: 8.03%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -6.64
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.31
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 60.31)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -1.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | H-17/202, 2nd Floor, Main Vikas Marg, New Delhi Delhi 110092 | catvision@catvisionindia.com http://www.catvisionindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Syed Athar Abbas | Managing Director |
| Mrs. Hina Abbas | Whole Time Director |
| Mr. Sudhir Damodaran | Non Executive Director |
| Mr. Raman Rajiv Misra | Independent Director |
| Capt. Seraj Mehdi | Independent Director |